Taevas
United StatesPersonal Care & Beauty
Product Registration
Product Registration for Personal Care & Beauty in United States
Taevas Global helps Personal Care & Beauty manufacturers navigate FDA cosmetic registration requirements under the Modernization of Cosmetics Regulation Act, turning complex compliance into a clear, accelerated path to the United States market.
Market
United States
Industry
Personal Care & Beauty
Service
Product Registration
Regulator
FDA Office of Cosmetics and Colors (OCAC)
Timeline
4-8 weeks
What We Deliver
Six Pillars of United States Personal Care & Beauty Intelligence
Our six interconnected pillars give Personal Care & Beauty manufacturers a complete picture of regulatory obligations, market dynamics, and commercial positioning in the United States.
01
FDA Regulatory Mapping
We conduct a thorough analysis of your product portfolio against FDA cosmetic and OTC drug classification rules, including MoCRA facility registration and product listing requirements. Our team identifies whether each SKU qualifies as a cosmetic, OTC drug, or combination product, preventing costly misclassification. You receive a clear regulatory roadmap before a single form is filed.
MoCRA facility registration and product listing compliance
Cosmetic vs. OTC drug classification analysis
Ingredient safety and prohibited substance review
How It Works
From Brief to Board-Ready Intelligence
Our four-step engagement takes Personal Care & Beauty manufacturers from initial product assessment to a fully registered, market-ready portfolio in the United States.
Step 1 · Day 1-2
Discovery & Portfolio Assessment
We begin with a structured intake session to understand your full product portfolio, target categories, manufacturing locations, and existing documentation. Each product is screened for FDA classification, MoCRA applicability, and labeling gaps. This assessment produces a prioritized compliance gap report before any regulatory work begins.
Taevas Approach
Our intake questionnaire covers product formulations, ingredient lists, intended claims, target retail channels, and manufacturing facility details. We cross-reference your portfolio against FDA's current Voluntary Cosmetic Registration Program (VCRP) records if applicable, and flag any products that may require OTC drug registration pathways. The output is a written gap analysis delivered within 48 hours of the kickoff call.
Market Snapshot
United States Personal Care & Beauty Market at a Glance
$0B
United States Beauty Market Size (2023)
0%
Projected Annual CAGR Through 2028
0+
New Cosmetic Brands Entering US Annually
0K+
Cosmetic Product Listings Filed with FDA
MoCRA Reshapes the Landscape
The Modernization of Cosmetics Regulation Act of 2022 represents the most significant overhaul of United States cosmetics law in over 85 years. Mandatory facility registration, product listing, and safety substantiation requirements are now in force, creating new compliance obligations for both domestic and foreign manufacturers. Companies that delay compliance risk import alerts and retail delisting.
FDA Enforcement Is Accelerating
FDA has significantly increased its cosmetic enforcement activity following MoCRA enactment, with a growing number of warning letters targeting unsubstantiated drug claims and labeling violations. Foreign manufacturers shipping to United States retailers face heightened scrutiny at the border, particularly for products containing ingredients not recognized under United States standards. Proactive registration dramatically reduces enforcement risk.
Clean Beauty Drives Category Growth
Consumer demand for clean, sustainable, and transparent beauty products is reshaping purchasing behavior across all United States retail channels, with clean beauty estimated to represent over 20 percent of total beauty sales by 2025. Retailers including Sephora, Target, and Whole Foods maintain proprietary restricted ingredient lists that go beyond FDA minimums. Brands must navigate both regulatory and retailer compliance simultaneously.
Digital & DTC Channels Lower Entry Barriers
Direct-to-consumer e-commerce and social commerce platforms have lowered the capital required for international Personal Care & Beauty brands to test the United States market, with Amazon Beauty and TikTok Shop emerging as significant first-entry channels. However, these platforms impose their own compliance documentation requirements and are subject to FDA jurisdiction. A registered, compliant product portfolio is a prerequisite for sustained DTC growth.
What's Included
Everything in Your Report
Every Product Registration engagement for Personal Care & Beauty in the United States delivers eight structured outputs designed to take your team from compliance gap to market-ready launch.
Regulatory Gap Analysis Report
A product-by-product assessment of your portfolio against FDA MoCRA, OTC drug, and labeling requirements, with prioritized remediation actions and estimated effort for each gap.
FDA Submission Package
Fully prepared and reviewed product listing and facility registration submissions for FDA Cosmetics Direct, formatted to agency standards and ready for electronic filing.
Ingredient & Claims Compliance Dossier
A comprehensive review of all ingredient declarations against FDA prohibited and restricted lists, paired with a claim substantiation file addressing FTC and FDA advertising standards.
Safety Substantiation Summary
A coordinated safety assessment summary prepared in alignment with MoCRA requirements, covering toxicological profile, intended use, and adverse event reporting protocol.
Retailer Compliance Package
A buyer-ready compliance documentation set tailored to the requirements of major United States retailers including Ulta Beauty, Sephora, Target, and Amazon, reducing vendor onboarding time.
Facility Registration Confirmation File
Official FDA facility registration confirmation records for all manufacturing and processing sites, organized by site with renewal deadline calendar and biennial update reminders.
Label Artwork Compliance Brief
A detailed label review and artwork brief covering INCI ordering, net quantity format, principal display panel requirements, and state-specific disclosures including California Prop 65.
12-Month Post-Market Compliance Calendar
A forward-looking regulatory calendar covering FDA renewal deadlines, anticipated rulemaking milestones, and state-level legislative dates that may affect your United States product portfolio.
Who This Is For
Built for These Situations
Market Entry
International Brand Entering the United States for the First Time
You have a proven product line in your home market and are ready to expand into the United States, but MoCRA's new facility registration and product listing requirements are unfamiliar territory. Your team lacks in-house FDA expertise and needs a partner who can translate your existing safety documentation into United States-compliant formats quickly. Speed to shelf is critical as your retail partnership window is time-bound.
Outcome
A fully registered product portfolio and compliant label suite ready for United States retail onboarding within eight weeks.
Next Steps
After Product Registration, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your United States Opportunity?
Partner with Taevas Global to navigate FDA registration requirements and bring your Personal Care & Beauty products to one of the world's most valuable beauty markets with confidence and speed.
End-to-end FDA MoCRA registration managed by specialists
Label and claims compliance reviewed before submission
Retailer-ready compliance documentation included
Ongoing post-market monitoring to protect your United States access